Q&A: Increasing awareness around digital therapeutics key to realising full potential
It’s been a rocky few years for digital therapeutics (DTx) with some setbacks, including the demise of Pear Therapeutics, along…
All articles by Sally Turner
Sally Turner
Sally Turner is a UK-based health journalist who has written on a diverse range of topics including the microbiome, gene therapy, the patient relationship, and pharmaceutical pollution. She is particularly interested in pharmaceutical advances related to sexual health, women's healthcare, autoimmune diseases, and chronic pain.
-
-
The opioid crisis: Different delivery systems tackle treatment needs
The over-prescription of opioid pain relievers such as oxycontin and the widespread availability of potent synthetic opioids such as fentanyl…
-
Pharma breakthroughs: 10 novel drug approvals that made headlines in 2023
Every year, the U.S. Food and Drug Administration (FDA) approves a wide range of new drugs and biological products. This…
-
Childproof packaging: How things are changing for consumer drugs
While childproof packaging for pharmaceuticals is of fundamental importance and an ethical duty for the industry, multiple drugs in recent…
-
Cancer treatment uncertainty: European nations struggle with drug shortages
With drug shortages still a global issue, medications to treat cancer are in particularly short supply. Europe is running out…
-
Robotics: Transforming cell and gene therapy manufacturing
In recent years, cell therapies have resulted in the successful treatment of conditions ranging from lymphoid cancers to fistulas associated…
-
From Europe to Latin America: Driving access to affordable biosimilars
In the last two decades, biosimilars have generated savings for healthcare systems while improving patient access to vital medications, but…
-
Clinics ration supplies as cancer drug shortages proliferate
Drug shortages have been in the news for several years, but they worsened during the Covid-19 pandemic, and several pharmacy, regulatory, and…
-
Cybersecurity in pharma: Securing the future
Earlier this year, Sun Pharmaceutical Industries, one of India’s largest generic drug producers, reported a major cybersecurity breach, impacting its…
-
The emergence of tranq amidst the fentanyl crisis
In February, the FDA issued an alert restricting the import of the veterinary sedative xylazine or tranq and the ingredients used to…